Program
formoterol
Also written as “Formoterol Fumarate”, “budesonide/formoterol” and “Formoterol”.
Its studies are mostly in Asthma · Pulmonary Disease, Chronic Obstructive · Bronchitis, Chronic · Asthma, Exercise-Induced, led by 18 companies.
Drug pageFormoterol: every studyMany companies study it; this page follows only the 137 they lead. All 190 studies, academic ones too, with its approvals and label.Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| AstraZenecaits history only | 632 open or running | phase 4since Jan 4, 2006 | Sep 13, 2005 | May 31, 2027phase 4 · NCT07073950 |
| Chiesi Farmaceutici | 200 open or running | phase 4since Nov 29, 2010 | Oct 30, 2006 | none ahead |
| Viatrisits history only | 160 open or running | phase 4since Nov 29, 2011 | Sep 13, 2005 | none ahead |
| Novartisits history only | 60 open or running | phase 4since Jul 26, 2005 | Jul 26, 2005 | none ahead |
| Sumitomo Pharmaits history only | 60 open or running | phase 4since Jan 17, 2007 | Jul 8, 2003 | none ahead |
| SkyePharmaits history only | 50 open or running | phase 3since Oct 27, 2006 | Oct 27, 2006 | none ahead |
| Eurofarma Laboratoriosits history only | 30 open or running | phase 3since Oct 23, 2009 | Oct 23, 2009 | none ahead |
| Mundipharmaits history only | 30 open or running | phase 4since Jun 15, 2015 | Oct 14, 2009 | none ahead |
| Ache Laboratorios Farmaceuticosits history only | 20 open or running | phase 3since Mar 9, 2011 | Mar 9, 2011 | none ahead |
| Boehringer Ingelheimits history only | 20 open or running | phase 2since Sep 11, 2014 | Sep 11, 2014 | none ahead |
| Intech Biopharmits history only | 20 open or running | phase 1since Jul 25, 2016 | Jul 25, 2016 | none ahead |
| Orion Corporation, Orion Pharmaits history only | 20 open or running | phase 2since Aug 24, 2009 | Aug 24, 2009 | none ahead |
| Zambon SpAits history only | 20 open or running | phase 1since Sep 2, 2014 | Sep 2, 2014 | none ahead |
| Chenpon Pharmaceuticalits history only | 10 open or running | phase 3since Aug 24, 2026 | Aug 24, 2026 | none ahead |
| Kindeva Drug Deliveryits history only | 10 open or running | phase 3since Jan 6, 2017 | Jan 6, 2017 | none ahead |
| Merckits history only | 10 open or running | phase 4since Aug 30, 2005 | Aug 30, 2005 | none ahead |
| Neutec Ar-Ge San ve Tic A.Şits history only | 10 open or running | phase 4since Oct 6, 2016 | Oct 6, 2016 | none ahead |
| Teva Pharmaceutical Industriesits history only | 10 open or running | phase 3since Jul 1, 2015 | Jul 1, 2015 | none ahead |
Also a collaborator on its studies: Parexel, CISCRP, eResearchTechnology, Menarini Group, Integrated Therapeutics Group and Pacira BioSciences.
How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.
History and studies of Chiesi Farmaceutici only; the figures above count every company.
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
Before these, 5 studies since Oct 30, 2006.
- Sep 3, 2009Phase 3 study in Pulmonary Disease, Chronic ObstructiveNCT00972140 · 457 enrolled · Poland
- Nov 29, 2010Phase 4 study in Pulmonary Disease, Chronic ObstructiveNCT01344655 · 16 enrolled · United Kingdom
- Apr 21, 20112 phase 2 studiesNCT01343745, NCT01349257
- Jun 9, 2011Phase 1 study in Pulmonary Disease, Chronic ObstructiveNCT01398111 · 44 enrolled · Belgium
- Oct 11, 2011Phase 3 study in AsthmaNCT01475032 · 638 enrolled · Bulgaria, France, Germany and more
- Apr 23, 2012Phase 2 study in AsthmaNCT01584492 · 59 enrolled · Poland, Ukraine
- Aug 3, 2012Phase 3 study in Asthma in ChildrenNCT01658891 · Denmark
- Aug 5, 2013Phase 3 study in Pulmonary Disease, Chronic ObstructiveNCT01917331 · 1,368 enrolled · Hungary
- Jan 9, 2014Phase 1 study in Pulmonary Disease, Chronic ObstructiveNCT02040597 · 42 enrolled · Poland
- Apr 11, 2014Phase 1 study in Pulmonary Disease, Chronic ObstructiveNCT02119234 · 36 enrolled · Poland
- Nov 15, 2016Phase 1 study in Pulmonary Disease, Chronic ObstructiveNCT02975843 · 28 enrolled
- Aug 23, 2017Phase 3 study in Pulmonary Disease, Chronic ObstructiveNCT03268226 · 20 enrolled · Belgium, Hungary
- May 3, 2021Phase 3 study in Pulmonary Disease, Chronic ObstructiveNCT04876677 · 25 enrolled · Belgium, Hungary
- Mar 4, 2022Phase 3 study in AsthmaNCT05292586 · 1,377 enrolled · United States
TargetBeta
Not stated by its company or a source we have read. Most early programs say nothing of it.
Studies
All 20 Chiesi Farmaceutici leads, newest first. Each opens its study page.
| Study | Phase | Status | Primary completion | Size |
|---|---|---|---|---|
| NCT05292586Asthma · United States | 3 | Completed | Jun 24, 2024 | 1,377 |
| NCT04876677Pulmonary Disease, Chronic Obstructive · Belgium, Hungary | 3 | Completed | Jan 3, 2022 | 25 |
| NCT03268226Pulmonary Disease, Chronic Obstructive · Belgium, Hungary | 3 | Completed | Jan 30, 2019 | 20 |
| NCT02975843Pulmonary Disease, Chronic Obstructive | 1 | Completed | Mar 21, 2017 | 28 |
| NCT02119234Pulmonary Disease, Chronic Obstructive · Poland | 1 | Completed | Feb 2015 | 36 |
| NCT02040597Pulmonary Disease, Chronic Obstructive · Poland | 1 | Completed | Apr 2015 | 42 |
| NCT01917331Pulmonary Disease, Chronic Obstructive · Hungary | 3 | Completed | Jan 14, 2016 | 1,368 |
| NCT01658891Asthma in Children · Denmark | 3 | Withdrawn | Nov 2015 | 0 |
| NCT01584492Asthma · Poland, Ukraine | 2 | Completed | Feb 2013 | 59 |
| NCT01475032Asthma · Bulgaria, France, Germany and more | 3 | Completed | Sep 2012 | 638 |
| NCT01398111Pulmonary Disease, Chronic Obstructive · Belgium | 1 | Completed | Aug 2011 | 44 |
| NCT01349257Asthma · United Kingdom | 2 | Completed | Jun 2011 | 24 |
| NCT01343745Mild Persistent Asthma · United Kingdom | 2 | Completed | Aug 2008 | 18 |
| NCT01344655Pulmonary Disease, Chronic Obstructive · United Kingdom | 4 | Completed | Sep 2012 | 16 |
| NCT00972140Pulmonary Disease, Chronic Obstructive · Poland | 3 | Completed | Apr 2006 | 457 |
| NCT00861926Asthma · Bulgaria, Croatia, Czechia and more | 3 | Completed | Dec 7, 2010 | 1,714 |
| NCT00742248Pulmonary Disease, Chronic Obstructive · Italy | 2 | Completed | May 2005 | 54 |
| NCT00476099Pulmonary Disease, Chronic Obstructive · France | 3 | Completed | Aug 2008 | 828 |
| NCT00413387Asthma · Austria, Poland, Ukraine | 3 | Completed | Aug 2005 | 219 |
| NCT00394368Asthma · Poland, Ukraine | 3 | Completed | 180 |
How it is read
Names in the registry
- “Formoterol Fumarate”, 14 entries
- “budesonide/formoterol”, 10 entries
- “Formoterol”, 9 entries
- “Fluticasone Propionate/Formoterol Fumarate”, 9 entries
- “BGF MDI 320/14.4/9.6 μg”, 6 entries
Conditions, from the studies’ own filings
- Asthma, 75 studies
- Pulmonary Disease, Chronic Obstructive, 71 studies
- Bronchitis, Chronic, 2 studies
- Asthma, Exercise-Induced, 1 study
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.